SIREN : 391442381
PRINCE MEDICAL is a French company founded 32 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in ERCUIS (60530), this company of category PME shows in 2024 a revenue of 13.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13 924 563 € | 15 421 600 € | 14 042 131 € | 11 302 786 € | 13 176 784 € | 14 927 535 € | 3 471 083 € | 12 757 718 € | 13 809 528 € | 14 574 588 € |
| Net income | 772 070 € | 587 199 € | 346 226 € | -3 347 € | 3 571 809 € | 1 131 729 € | -1 213 458 € | 243 599 € | 518 929 € | 714 986 € |
| EBITDA | 953 139 € | 713 811 € | 528 430 € | 76 729 € | 561 719 € | 658 325 € | 33 078 € | 316 295 € | 559 732 € | 1 122 617 € |
| Net margin | 5.5% | 3.8% | 2.5% | -0.0% | 27.1% | 7.6% | -35.0% | 1.9% | 3.8% | 4.9% |
In 2024, PRINCE MEDICAL achieves revenue of 13.9 M€. Activity remains stable over the period (CAGR: -0.6%). Slight decline of -10% vs 2023. After deducting consumption (9.2 M€), gross margin stands at 4.7 M€, i.e. a rate of 34%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 953 k€, representing 6.8% of revenue. Positive scissor effect: EBITDA margin improves by +2.2 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 772 k€, i.e. 5.5% of revenue. This profit can be retained or distributed to shareholders.
13 924 563 €
4 734 713 €
953 139 €
851 253 €
772 070 €
6.8%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 6.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
0.0%
77.652%
6.463%
0.0
31.0%
In 2024, the debt ratio of PRINCE MEDICAL (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of PRINCE MEDICAL (77.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of PRINCE MEDICAL (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 397.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.
397.204
0.073
In 2024, the liquidity ratio of PRINCE MEDICAL (397.20) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of PRINCE MEDICAL (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 44 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 71 days. Favorable situation: supplier credit is longer than customer credit by 27 days. Inventory turnover is 77 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 184 days of revenue, i.e. 7.1 M€ to permanently finance.
7 128 819 €
44 j
71 j
77 j
184 j
Based on 57 transactions of similar company sales
(all years),
the value of PRINCE MEDICAL is estimated at
2 627 906 €
(range 787 453€ - 5 147 751€).
With an EBITDA of 953 139€, the sector multiple of 2.5x is applied.
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PRINCE MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of PRINCE MEDICAL in 2024 is 13.9 M€.
Yes, PRINCE MEDICAL generated a net profit of 772 k€ in 2024.
The headquarters of PRINCE MEDICAL is located in ERCUIS (60530), in the department Oise.
The tax return of PRINCE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PRINCE MEDICAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.